Diane Kadidlo

Massive ex Vivo Expansion of Human Natural Regulatory T Cells (T _regs ) with Minimal Loss of in Vivo Functional Activity

Keli L. Hippen, Sarah C. Merkel, Dawn K. Schirm et al. · Science Translational Medicine · 2011 · 361 citations · Full text

Life Sciences, Cell Biology, Immunology +15

Good manufacturing practices production of natural killer cells for immunotherapy: a six‐year single‐institution experience

David H. McKenna, Darin Sumstad, Nancy Bostrom et al. · Transfusion · 2007 · 115 citations

Life Sciences, Immunology, Oncology +17

Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples

Vinçent Laroche, David H. McKenna, Gary Moroff et al. · Transfusion · 2005 · 103 citations

Medicine, Cell Biology, Hematology +17

Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction

Jay H. Traverse, David H. McKenna, Karen Harvey et al. · American Heart Journal · 2010 · 90 citations

Medicine, Cardiology, Internal Medicine +11

First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings

Margaret L. MacMillan, Keli L. Hippen, David H. McKenna et al. · Blood Advances · 2021 · 70 citations · Full text

Life Sciences, Hematology, Immunology +17